Six patients receiving thiazide diuretics were referred for evaluation of mild to moderate hypercalcaemia (serum calcium 2.65-298 mmol/l). All patients were considered to be suffering from primary hyperparathyroidism. Withdrawal of the diuretic was followed by a reduction in the serum calcium, one patient becoming normocalcaemic.
Introduction
Thiazide diuretics are widely used in clinical practice and their major effect on the promotion of the renal excretion of sodium is well known. Their effects on calcium metabolism appear to be less well appreciated. The renal excretion of calcium is consistently reduced by thiazide diuretics (Higgins et al., 1964) ; a less frequent response is hypercalcaemia.
The advent of multichannel autoanalysers into clinical practice has brought to light more and more patients with unsuspected hypercalcaemia (Heath, Hodgson and Kennedy, 1980) . In the majority this is mild and the result of primary hyperparathyroidism. Six patients with hypercalcaemia are reported, 4 of whom were discovered on routine biochemical screening. All the patients were receiving thiazide diuretics withdrawal of which was accompanied by a fall in the serum calcium, one patient becoming normocalcaemic.
Patients and methods
The patients, 2 men and 4 women, were studied in a metabolic unit, and all had been referred from other clinicians for investigation of hypercalcaemia. The clinical details are shown in (Higgins et al., 1964) . Hypercalcaemia occurs less frequently. In most instances this is almost wholly explained through the effects (Adams et al., 1970) . The findings of the present studies are in agreement with previous observations of Brickman et al. (1972) . Withdrawal of the diuretic was associated with an increase in the urinary calcium, and a fall in the serum calcium. The patients reported here had primary hyperparathyroidism, and in one the serum calcium fell to normal when the diuretic was withdrawn.
The mechanisms responsible for thiazide-induced hypercalcaemia are not fully understood, but a major factor is the associated reduction in the renal excretion of calcium. This effect is partly attributable to a reduction in the filtered load of calcium (through decreases in the glomerular filtration rate), and partly to increased renal tubular reabsorption of calcium. Both effects can be abolished with sodium replacement (Brickman et al., 1972) and occur independently of parathyroid hormone (Porter et al., 1978) .
Although there is good evidence that thiazideinduced hypercalcaemia is largely explained through the reduction in the renal excretion of calcium, extra-renal mechanisms play a part. Patients with advanced renal failure and minimal urinary outputs of calcium develop hypercalcaemia when given thiazides (Koppel et al., 1970) . This observation suggests that under these conditions thiazides increase the losses of calcium from bone. The reported effects of thiazides on the intestinal absorption of calcium are conflicting (Ehrig, Harrison and Wilson, 1974) , some studies showing no effect, some increased absorption and others, reduced absorption.
The vast majority of patients receiving thiazides have normal parathyroid function, and very few of them develop overt hypercalcaemia. This is predictable and explicable in terms of normal serum calcium homoeostasis, and its relation to parathyroid function. Non-parathyroid-induced increases in the serum calcium cause a reduction in parathyroid secretion with a consequent fall in the renal tubular reabsorption of calcium, calcium release from bone and possibly intestinal calcium absorption (through decreased renal production of 1,25 dihydroxycholecalciferol). These effects cause a net fall in the entry of calcium into the extra-cellular space and, within limits, they offset the tendency to hypercalcaemia. Thiazides promote the entry of calcium into the extracellular space. It may be predicted that patients with normal parathyroid function will show a reduction in serum iPTH when given thiazides; there is some evidence that this occurs (Stote et al., 1972) . In contrast, patients with primary hyperparathyroidism, and hence autonomous parathyroid function, may be expected to show no reduction in serum iPTH with thiazides, and hypercalcaemia is to be expected. The findings in the present study support this conclusion; thiazides had no effect on the serum 
